274 related articles for article (PubMed ID: 31320608)
41. Protein kinase CK2 is required for the recruitment of 53BP1 to sites of DNA double-strand break induced by radiomimetic drugs.
Guerra B; Iwabuchi K; Issinger OG
Cancer Lett; 2014 Apr; 345(1):115-23. PubMed ID: 24333722
[TBL] [Abstract][Full Text] [Related]
42. Nanoscopic analysis of 53BP1, BRCA1 and Rad51 reveals new insights in temporal progression of DNA-repair and pathway choice.
Schwarz B; Friedl AA; Girst S; Dollinger G; Reindl J
Mutat Res; 2019 Nov; 816-818():111675. PubMed ID: 31302572
[TBL] [Abstract][Full Text] [Related]
43. 53BP1 and BRCA1 control pathway choice for stalled replication restart.
Xu Y; Ning S; Wei Z; Xu R; Xu X; Xing M; Guo R; Xu D
Elife; 2017 Nov; 6():. PubMed ID: 29106372
[TBL] [Abstract][Full Text] [Related]
44. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.
Goodarzi AA; Jeggo P; Lobrich M
DNA Repair (Amst); 2010 Dec; 9(12):1273-82. PubMed ID: 21036673
[TBL] [Abstract][Full Text] [Related]
45. Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response.
Huang CY; Hsieh FS; Wang CY; Chen LJ; Chang SS; Tsai MH; Hung MH; Kuo CW; Shih CT; Chao TI; Chen KF
Eur J Cancer; 2018 Oct; 102():10-22. PubMed ID: 30103095
[TBL] [Abstract][Full Text] [Related]
46. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
47. Regulation of repair pathway choice at two-ended DNA double-strand breaks.
Shibata A
Mutat Res; 2017 Oct; 803-805():51-55. PubMed ID: 28781144
[TBL] [Abstract][Full Text] [Related]
48. Downregulation of MDC1 and 53BP1 by short hairpin RNA enhances radiosensitivity in laryngeal carcinoma cells.
Gou Q; Xie Y; Liu L; Xie K; Wu Y; Wang Q; Wang Z; Li P
Oncol Rep; 2015 Jul; 34(1):251-7. PubMed ID: 25976740
[TBL] [Abstract][Full Text] [Related]
49. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
Wang H; Li H; Zhang L; Yang D
Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
[TBL] [Abstract][Full Text] [Related]
50. SCAI promotes DNA double-strand break repair in distinct chromosomal contexts.
Hansen RK; Mund A; Poulsen SL; Sandoval M; Klement K; Tsouroula K; Tollenaere MA; Räschle M; Soria R; Offermanns S; Worzfeld T; Grosse R; Brandt DT; Rozell B; Mann M; Cole F; Soutoglou E; Goodarzi AA; Daniel JA; Mailand N; Bekker-Jensen S
Nat Cell Biol; 2016 Dec; 18(12):1357-1366. PubMed ID: 27820601
[TBL] [Abstract][Full Text] [Related]
51. Modification of radiation-induced DNA double strand break repair pathways by chemicals extracted from Podophyllum hexandrum: an in vitro study in human blood leukocytes.
Srivastava NN; Shukla SK; Yashavarddhan MH; Devi M; Tripathi RP; Gupta ML
Environ Mol Mutagen; 2014 Jun; 55(5):436-48. PubMed ID: 24500925
[TBL] [Abstract][Full Text] [Related]
52. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer.
Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ
Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800
[TBL] [Abstract][Full Text] [Related]
53. BRCA1 and 53BP1 regulate reprogramming efficiency by mediating DNA repair pathway choice at replication-associated double-strand breaks.
Georgieva D; Wang N; Taglialatela A; Jerabek S; Reczek CR; Lim PX; Sung J; Du Q; Horiguchi M; Jasin M; Ciccia A; Baer R; Egli D
Cell Rep; 2024 Apr; 43(4):114006. PubMed ID: 38554279
[TBL] [Abstract][Full Text] [Related]
54. Jumonji domain-containing protein 2B silencing induces DNA damage response via STAT3 pathway in colorectal cancer.
Chen L; Fu L; Kong X; Xu J; Wang Z; Ma X; Akiyama Y; Chen Y; Fang J
Br J Cancer; 2014 Feb; 110(4):1014-26. PubMed ID: 24473398
[TBL] [Abstract][Full Text] [Related]
55. MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor.
Takahashi M; Koi M; Balaguer F; Boland CR; Goel A
J Biol Chem; 2011 Apr; 286(14):12157-65. PubMed ID: 21285347
[TBL] [Abstract][Full Text] [Related]
56. RIF1 acts in DNA repair through phosphopeptide recognition of 53BP1.
Setiaputra D; Escribano-Díaz C; Reinert JK; Sadana P; Zong D; Callen E; Sifri C; Seebacher J; Nussenzweig A; Thomä NH; Durocher D
Mol Cell; 2022 Apr; 82(7):1359-1371.e9. PubMed ID: 35216668
[TBL] [Abstract][Full Text] [Related]
57. Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair.
Yang L; Shen C; Estrada-Bernal A; Robb R; Chatterjee M; Sebastian N; Webb A; Mo X; Chen W; Krishnan S; Williams TM
Nucleic Acids Res; 2021 Nov; 49(19):11067-11082. PubMed ID: 34606602
[TBL] [Abstract][Full Text] [Related]
58. The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX.
Hu J; Cai G; Xu Y; Cai S
Curr Mol Med; 2016; 16(1):70-82. PubMed ID: 26695693
[TBL] [Abstract][Full Text] [Related]
59. 53BP1-mediated recruitment of RASSF1A to ribosomal DNA breaks promotes local ATM signaling.
Tsaridou S; Velimezi G; Willenbrock F; Chatzifrangkeskou M; Elsayed W; Panagopoulos A; Karamitros D; Gorgoulis V; Lygerou Z; Roukos V; O'Neill E; Pefani DE
EMBO Rep; 2022 Aug; 23(8):e54483. PubMed ID: 35758159
[TBL] [Abstract][Full Text] [Related]
60. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
